Business Description
Med Life SA
ISIN : ROMEDLACNOR6
Total Employee Number:
240Compare
Compare
Traded in other countries / regions
M.Romania0RO5.UKO0C.Germany IPO Date
2017-04-05Description
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 4.08 | |||||
Debt-to-EBITDA | 6.58 | |||||
Interest Coverage | 1.75 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.9 | |||||
3-Year EBITDA Growth Rate | 12.7 | |||||
3-Year EPS without NRI Growth Rate | -32.1 | |||||
3-Year FCF Growth Rate | -40.1 | |||||
3-Year Book Growth Rate | 7.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 127.04 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.42 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
3-1 Month Momentum % | 42.55 | |||||
6-1 Month Momentum % | 42.55 | |||||
12-1 Month Momentum % | 717.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 110.6 | |||||
Days Sales Outstanding | 34.23 | |||||
Days Payable | 290.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -3.57 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.84 | |||||
Operating Margin % | 5.15 | |||||
Net Margin % | 0.05 | |||||
EBITDA Margin % | 12.58 | |||||
FCF Margin % | 0.36 | |||||
OCF Margin % | 6.31 | |||||
ROE % | 0.24 | |||||
ROA % | 0.03 | |||||
3-Year ROIIC % | -5.52 | |||||
ROC (Joel Greenblatt) % | 4.71 | |||||
ROCE % | 3.68 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5700 | |||||
Forward PE Ratio | 20.2 | |||||
PE Ratio without NRI | 1425 | |||||
Shiller PE Ratio | 186.55 | |||||
PEG Ratio | 75.8 | |||||
PS Ratio | 2.48 | |||||
PB Ratio | 12.24 | |||||
Price-to-Free-Cash-Flow | 670.59 | |||||
Price-to-Operating-Cash-Flow | 39.31 | |||||
EV-to-EBIT | 110.24 | |||||
EV-to-EBITDA | 29.78 | |||||
EV-to-Revenue | 3.75 | |||||
EV-to-FCF | 906.24 | |||||
Price-to-GF-Value | 8.18 | |||||
Price-to-Projected-FCF | 6.35 | |||||
Price-to-Peter-Lynch-Fair-Value | 142.19 | |||||
Earnings Yield (Greenblatt) % | 0.91 | |||||
FCF Yield % | 0.11 | |||||
Forward Rate of Return (Yacktman) % | 10.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Med Life SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil lei) | 2,437.423 | ||
| EPS (TTM) (lei) | 0.002 | ||
| Beta | 4.9951 | ||
| 3-Year Sharpe Ratio | 0.61 | ||
| 3-Year Sortino Ratio | 136.08 | ||
| Volatility % | 471.45 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (lei) | 0.038032 | ||
| 20-Day SMA (lei) | 11.3753 | ||
| 12-1 Month Momentum % | 717.38 | ||
| 52-Week Range (lei) | 1.39167 - 11.3753 | ||
| Shares Outstanding (Mil) | 530.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Med Life SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Med Life SA Stock Events
| Event | Date | Price (lei) | ||
|---|---|---|---|---|
| 4:1 Stock Split | 2023-09-01 | 1.39 (+0.00%) | ||
| 6:1 Stock Split | 2020-12-30 | 1.39 (+0.00%) |
Show
Entries
Med Life SA Frequently Asked Questions
What is Med Life SA(LTS:0RO5)'s stock price today?
The current price of LTS:0RO5 is lei11.38. The 52 week high of LTS:0RO5 is lei11.38 and 52 week low is lei1.39.
When is next earnings date of Med Life SA(LTS:0RO5)?
The next earnings date of Med Life SA(LTS:0RO5) is .
Does Med Life SA(LTS:0RO5) pay dividends? If so, how much?
Med Life SA(LTS:0RO5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Med Life SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers